Results 1 to 10 of about 1,928,223 (200)

Pan cohort immune biomarker of CD8 lymphocyte activation enabling HGSOC outcome prediction and treatment response. [PDF]

Discov Oncol
Liu X, Zhang Z, Wang B, Qin L, Fan N, Wang R, Yu X, Han Q, Lu Z, Kikete S, Shi F, Chu C, Zhang Y, Niu L, Wei R, Wu J, Li X.   +16 more
europepmc   +1 more source

The Polyamine Putrescine Is a Positive Regulator of Group 3 Innate Lymphocyte Activation. [PDF]

Immunohorizons, 2023
Sah P, Zenewicz LA.
europepmc   +1 more source

Lymphocyte Activation Gene 3 Regulation of Profibrotic Cytokines and Type I Collagen Production in Patients With Systemic Sclerosis. [PDF]

ACR Open Rheumatol
Aspari M, Greisen S, Hvid M, Ong VH, Denton CP, Abraham D, Deleuran B.   +6 more
europepmc   +1 more source

Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3). [PDF]

ACS Med Chem Lett, 2023
Abdel-Rahman SA, Rehman AU, Gabr MT.
europepmc   +1 more source

A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth. [PDF]

Biomater Res
Lee SM, Gurung S, Park MS, Vadevoo SMP, Gunassekaran GR, Kim MJ, Kim SH, Kim HJ, Park EJ, Lee S, Im W, Kim S, Lee B.   +12 more
europepmc   +1 more source

Efficacy and Safety of DNV3 (a Lymphocyte-activation Gene 3-blocking Antibody) Combined With Toripalimab and Chemotherapy in Advanced Melanoma: An Open-label, Single-arm Clinical Trial. [PDF]

MedComm (2020)
Lin J, Chen L, Chen L, Wang D, Lu Y, Zhang H, Chen P, Yan W, Xiao Z, Chen Y.   +9 more
europepmc   +1 more source

The Mitigating Effect of Combined Glucocorticoids with Immune Checkpoint Inhibitors on Lymphocyte Activation Gene-3 and Programmed Death-1 Expression. [PDF]

Eur J Immunol
Gertel S, Polachek A, Furer V, Dovrat TO, Avaky C, Broyde A, Nochimovitz H, Elkayam O.   +7 more
europepmc   +1 more source

Design of a prodrug bispecific antibody masked by a functional molecule for lymphocyte activation for cancer therapy. [PDF]

J Biol Eng
Miura D, Kato Y, Yasunaga M, Kumagai I, Asano R.   +4 more
europepmc   +1 more source

Genes of the "regulation of lymphocyte activation" pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors. [PDF]

Pituitary
Chiloiro S, Costanza F, Scaglione GL, Russo F, Nardelli C, Giampietro A, Mattogno PP, Lauretti L, Rindi G, De Marinis L, Gessi M, Bianchi A, Doglietto F, Capoluongo ED, Pontecorvi A.   +14 more
europepmc   +1 more source

LAG Time in the Era of Immunotherapy-New Molecular Insights Into the Immunosuppression Mechanism of Lymphocyte Activation Gene-3. [PDF]

Immunol Rev
Luca VC.
europepmc   +1 more source